Results of a randomized double-blind study evaluating luvadaxistat in adults with Friedreich ataxia.

Ann Clin Transl Neurol · 2021 · PMC8164851 · PMID 34018342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among the secondary endpoints, for the change in mFARS‐neuro, all treatment arms showed a trend toward less impairment after 12 weeks, but the luvadaxistat arms did not differ statistically from placebo (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.